Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Cytokinetics-Astellas Agree to Develop Muscle Treatments
Bloomberg
Tuesday, June 25, 2013 - 12:22pm
tags:
Astellas, Cytokinetics, muscle weakness, CK-2127107
Cempra's Platform Potentially Worth Billions In Battling Superbugs And MRSA
Seeking Alpha
Tuesday, June 25, 2013 - 12:20pm
tags:
Cempra, superbugs, Cubist Pharmaceuticals, Ariad Pharmaceuticals, Celldex, Trius Therapeutics
Safety Concern Halts Study of Seattle Genetics' Lymphoma Drug
TheStreet.com
Tuesday, June 25, 2013 - 12:19pm
tags:
Seattle Genetics, Adcetris, Hodgkin's lymphoma
Seattle Genetics, Bayer to Develop Less Symptomatic Cancer Drug
FOX Business
Tuesday, June 25, 2013 - 12:18pm
tags:
Seattle Genetics, Bayer, antibody-drug conjugate
Hormone Drugs Don’t Harm Brain for Some Menopausal Women
Bloomberg
Tuesday, June 25, 2013 - 12:16pm
tags:
menopause, HRT
6 Reasons Why Loss of Viagra Patent Will Not Harm Pfizer
Motley Fool
Tuesday, June 25, 2013 - 11:29am
tags:
Viagra, Pfizer, patents, Eli Lilly, GSK, erectile dysfunction
Eli Lilly Wins U.K. Patent Suit on J&J Alzheimer’s Research
Bloomberg
Tuesday, June 25, 2013 - 11:25am
tags:
Eli Lilly, UK, patents, JNJ, Alzheimer's disease
Impax Laboratories President and CEO Larry Hsu to retire, replacement search team named
Yahoo/AP
Tuesday, June 25, 2013 - 11:24am
tags:
Impax Laboratories, CEO
Isis Drug Shuts Down Gene Causing Higher Blood-Fat Levels
TheStreet.com
Tuesday, June 25, 2013 - 11:02am
tags:
Isis Pharmaceuticals, Amarin, Sanofi, ISIS-APOCIIIRx, hypertriglyceridemia
FDA draft guidance on generic eye drug push Allergen shares lower
Reuters
Tuesday, June 25, 2013 - 11:00am
tags:
FDA, generics, Allergan, Restasis
Merck & Co wins injunction against Indian firm over diabetes drugs
Reuters
Tuesday, June 25, 2013 - 10:53am
tags:
Merck, India, diabetes, Aprica Pharmaceuticals, MSD
Why Might This Play Shake Up the Cancer-Drug Industry?
Motley Fool
Tuesday, June 25, 2013 - 10:41am
tags:
cancer, JNJ, M&A, Aragon, prostate cancer
Sonendo closes on $27M for root canal device
Mass Device
Monday, June 24, 2013 - 3:12pm
tags:
Sonendo, dental, devices
Mela Sciences CEO resigns | Personnel Moves
Mass Device
Monday, June 24, 2013 - 3:11pm
tags:
MELA Sciences, CEO, Management, devices
DePuy Orthopaedics wins FDA approval for customized knee implant system
Mass Device
Monday, June 24, 2013 - 3:11pm
tags:
DePuy, FDA, knee, impants, devices
Abiomed conquers shareholder's lawsuit over Impella claims
Mass Device
Monday, June 24, 2013 - 3:10pm
tags:
Abiomed, Impella, devices, lawsuit, legal, stock
With FDA approval and $32M, Lombard eyes U.S. stent launch
FierceMedicalDevice
Monday, June 24, 2013 - 12:20pm
tags:
FDA, Lombard Medical, stent, devices, launch
St. Jude snags CE mark for flexible pacer
FierceMedicalDevice
Monday, June 24, 2013 - 12:20pm
tags:
St. Jude Medical, CE Mark, pacer, devices
Medtronic recalls breathing tube; FDA warns of deadly risk
FierceMedicalDevice
Monday, June 24, 2013 - 12:19pm
tags:
Medtronic, devices, FDA, recall
New York isn't the Only City that Doesn't Sleep: ResMed Survey Reveals Majority of Americans Suffer Through their Bed Partners' Snoring Instead of Seeking Help
Yahoo/PRNewswire
Monday, June 24, 2013 - 12:11pm
tags:
devices, sleep, sleep apnea, ResMed

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.